2019 was a strong year for IPOs, with the average return clocking up a very nice 36 per cent according to Bloomberg.

Time will tell if 2020 will be another good year but there are a handful of companies that have already announced their plans to join the ASX in the New Year. Here are six of them.


Emerald Clinics

It’s been a long time coming, but Emerald Clinics is due to list on February 7 once it successfully completes a $6m-$8m capital raising.

It is a medical cannabis company, but not a grower or a biotech. It wants to sell data on how medical cannabis works in people, believing this is what is holding the industry back.

Chairman Stewart Washer said in Emerald’s prospectus, “Emerald’s strategy is to become the leading, independent operator of data-driven, patient-centric, specialist cannabinoid management clinics across Australia and the world.”

READ MORE: The Pot Seat: Emerald’s Stewart Washer says they’re listing this year



4Dx is a med-tech with a lung imaging platform. It helps detect diseases such as lung cancer and identify side-effects to disease treatments. It uses no dyes whatsoever, needs no injections and uses 35 times less radiation than the next best scan, according to the ASX hopeful.

Back in October 4DX said the tech passed a 13-month clinical trial showing it was superior. Perfect timing, because CEO Andreas Fouras was seeking broker interest for an IPO that very same week. No date for listing has been set.

He told Stockhead the other major milestone he was targeting in 2020 was FDA approval. While 4DX’s lung imaging tech has not yet been approved in other markets, Fouras said because the FDA was the hardest, if 4Dx could make it in America it could make it anywhere.

READ MORE: 4Dx’s lung imaging technology just passed a clinical trial. Next step – an ASX listing


Little Green Pharma

Many cannabis companies on the ASX are growing overseas. But Little Green Pharma is growing locally in Western Australia and has just begun exports – starting with Germany.

Also in November, its home state Western Australia, caught up with the east allowing GPs to prescribe cannabis without having to refer patients to a specialist.

It was aiming for $10m under its IPO and raised the full amount in time for Christmas. The prospectus pens in listing for February 7.

READ MORE: WA slashes medicinal cannabis red tape; Aussie companies to benefit



What if there was a single integrated solution for managing the entire lifecycle of a corporate or commercial transaction? Thedocyard claims to be the solution for a function ripe for disruption.

It has a cloud-based platform that allows secure file sharing, collaboration between parties and workflow management solutions.

Chairman James Walker said the company was on a mission to “become the next Australian technology success story” with the UK being the first international market it is seeking growth in.

The listing date is set for February 14.



Another tech player looking to light up the boards in 2020 is COSOL, which is hoping to make a January 23 debut. The company’s focus is on businesses with asset-intensive industries such as manufacturing, energy, utilities and transportation.

COSOL’s solutions help business maximise the use, economic return and viability of these assets. It anticipates the market for this type of software (Enterprise Asset Management) to grow at a compound annual growth rate of 13.3 per cent between 2019 and 2024.

Its clients include many of the top miners such as Rio Tinto (ASX:RIO), BHP (ASX:BHP), Fortescue Metals Group (ASX:FMG), Newcrest Mining (ASX:NCM) and St Barbara (ASX:SBM).


Kaiser Reef

Don’t worry, we haven’t forgotten about resources IPOs. This company is a gold explorer focused on New South Wales, sandwiched in between projects operated by Alkane Resources (ASX:ALK) and Newcrest.

Adrian Byass, who has taken on the role of chairman, says the company’s Stuart Town gold project covers a significant historic gold field that has had very limited exploration in a “premier district”.

According to Kaiser Reef, its ground witnessed “significant historical production” exceeding 170,000 ounces of gold sourced from many relatively small lode and alluvial gold sources.

It is raising $4.5m and is set to list on February 27.

READ MORE: IPO Watch: Moly Mines duo pair up again for new gold IPO